Rhaeos

Rhaeos is on track to launch its first product next year. Read More →

Rhaeos, Inc., a private medical device company focused on the care of patients with hydrocephalus, announced today it was awarded a $4 million, multi-year grant from the National Institutes of Health (NIH) Small Business Innovation Research (SBIR) program through the National Institute of Neurological Disorders and Stroke (NINDS). Read More →

The shunts that relieve fluid pressure in the brain are failure-prone, but current imaging methods don’t provide enough data to assess their function. Rhaeos is seeking to fill that gap with a wearable flow monitor that yields insightful data in minutes.Read More →

At Advamed’s Medtech Conference, the top 5 finalists pitched with the Grand Prize awarded to Rhaeos CEO, Anna Lisa Somera. Rhaeos has a novel wireless, wearable sensor for the monitoring of shunts in patients with Hydrocephalus. Read More →

Rhaeos, a company based in Illinois, is trying to bring to market its FlowSense device, a wearable non-invasive patch that looks like a bandage and which can provide data on flow through a shunt.  Read More →